Cargando…

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD

BACKGROUND: Reduced cerebrovascular function and accumulation of tau pathology are key components of cognitive decline in Alzheimer’s disease (AD). Recent multimodal neuroimaging studies show a correlation between cortical tau accumulation and reduced cerebral perfusion. However, animal models predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryant, Annie G., Manhard, Mary K., Salat, David H., Rosen, Bruce R., Hyman, Bradley T., Johnson, Keith A., Huang, Susie, Bennett, Rachel E., Yen, Yi-Fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822690/ https://www.ncbi.nlm.nih.gov/pubmed/34825871 http://dx.doi.org/10.2174/1567205018666211126113904

Ejemplares similares

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study
por: Bullich, Santiago, et al.
Publicado: (2022)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

Partial reduction of microglia does not affect tau pathology in aged mice
por: Bennett, Rachel E., et al.
Publicado: (2018)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau
por: Dickerson, Bradford C., et al.
Publicado: (2013)

Cortical graph neural network for AD and MCI diagnosis and transfer learning across populations
por: Wee, Chong-Yaw, et al.
Publicado: (2019)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
por: Mate De Gerando, Anastasie, et al.
Publicado: (2023)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
por: Pak, Victoria M., et al.
Publicado: (2020)

Brain signatures based on structural MRI: Classification for MCI, PMCI, and AD
por: Gonuguntla, Venkateswarlu, et al.
Publicado: (2022)

Different tau species lead to heterogeneous tau pathology propagation and misfolding
por: Dujardin, Simon, et al.
Publicado: (2018)

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †
por: Zhao, Yan, et al.
Publicado: (2022)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid
por: Luis, Cheryl A., et al.
Publicado: (2011)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD
por: Richter, Nils, et al.
Publicado: (2019)

Free Water in White Matter Differentiates MCI and AD From Control Subjects
por: Dumont, Matthieu, et al.
Publicado: (2019)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
por: Bertens, Daniela, et al.
Publicado: (2019)

Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease
por: Tai, Hwan-Ching, et al.
Publicado: (2014)

Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI
por: Carlson, Mackenzie L., et al.
Publicado: (2020)

Early MCI-to-AD Conversion Prediction Using Future Value Forecasting of Multimodal Features
por: Minhas, Sidra, et al.
Publicado: (2021)

Effects of White Matter Hyperintensities on Verbal Fluency in Healthy Older Adults and MCI/AD
por: Kaskikallio, Alar, et al.
Publicado: (2021)

Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable AD
por: Duchesne, Simon, et al.
Publicado: (2011)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data
por: Ye, Jieping, et al.
Publicado: (2012)

Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR
por: Goubran, Maged, et al.
Publicado: (2015)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

Predicting Conversion from MCI to AD Combining Multi-Modality Data and Based on Molecular Subtype
por: Li, Hai-Tao, et al.
Publicado: (2021)

Multi-Modal Feature Selection with Feature Correlation and Feature Structure Fusion for MCI and AD Classification
por: Jiao, Zhuqing, et al.
Publicado: (2022)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Exploration of time–frequency reassignment and homologous inter-hemispheric asymmetry analysis of MCI–AD brain activity
por: Nimmy John, T., et al.
Publicado: (2019)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
por: Tao, Ye, et al.
Publicado: (2020)

In the Hands of Hypnos: Associations between Sleep, Cognitive Performance and Financial Capacity in aMCI and Mild AD
por: Giannouli, Vaitsa, et al.
Publicado: (2023)

A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD
por: McNett, Sienna D., et al.
Publicado: (2023)

Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids
por: Lathuiliere, Aurelien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b85mlk14t4vhj46fqlk1rmcunu